Image Credit: © photon_photo – stock.adobe.com While a lot has changed in the past five years in clinical research, the most common findings from Food and Drug Administration (FDA) inspection of research…
Category: Medicine
The Twists and Turns in Biopharma Dealmaking: 2024 Trends
Spikes and valleys in M&A and dealmaking activity have been fairly routine and expected occurrences over the years in the biopharmaceutical sector. Just when they’ll strike, however, and the trajectories triggered as…
Standardizing Global Medicinal Product Documentation for Enhanced Patient Safety, Regulatory Efficiency in the Pharmaceutical Industry
Image credit: Mike Mareen | stock.adobe.com The pharmaceutical industry is characterized by a multitude of products with varying complexities and properties, each designed to improve human health and well-being. However, amidst this…
Micah Lieberman of ClinEco and CHI Speaks on the SCOPE Conference
Applied Clinical Trials: SCOPE Europe was held in Barcelona, Spain last October. Could you give our audience an overview of that? Micah Lieberman: SCOPE Europe is interesting because it’s Europe, it’s not…
The Evolving Role of AI in Shifting the Bottleneck in Early Drug Discovery
Image credit: Tierney | stock.adobe.com The cost of drug discovery—the process of R&D that brings new drugs to patients to address unmet medical needs—has grown exponentially over the past few decades. It…
FDA Expands Indication for Dupixent in Eosinophilic Esophagitis to Include Children Under 12 Years
Image credit: Yurii Kibalnik | stock.adobe.com The FDA has approved an expanded indication for Regeneron Pharmaceuticals’ and Sanofi’s Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in patients aged 1 to 11 years weighing at…
Phase IIIb VISIBLE Trial Shows Efficacy of Tremfya Treating Scalp Psoriasis in People of Color
Image credit: pongmoji | stock.adobe.com Johnson & Johnson has announced positive results from the Phase IIIb VISIBLE clinical trial for Tremfya (guselkumab) in the treatment of scalp psoriasis. According to the results,…
Life Sciences Accounting & Reporting Congress, 3/26-3/28/24
March 26-28, 2024 Hilton at Penns Landing | Philadelphia, PA Access the Latest Intelligence, Accounting Reporting Standards, Regulatory Changes and Transformational Strategies to Advance Your Financial Processes The Premier Event for CFOs,…
Bristol Myers Squibb Enhances Early Stage Oncology Clinical Pipeline With Mirati Acquisition
Image credit: Tada Images | stock.adobe.com Bristol Myers Squibb (BMS) has completed its acquisition of Mirati Therapeutics, Inc., which is now a wholly owned subsidiary of the company.1 The definitive merger agreement…
Prilenia Announces Plans to Initiate Global Phase III Study of Novel ALS Treatment
Image Credit: © Aerial Mike – stock.adobe.com Prilenia Therapeutics B.V. has announced it will present clinical data supporting a future Phase III study of the investigational therapy pridopidine for amyotrophic lateral sclerosis…